Advances of researches on astrocytes in inflammatory diseases of central nervous system

doi:10.16352/j.issn.1001-6325.2023.04.0665

Abstract

Abstract: Astrocytes respond to various forms of central nervous system (CNS) damage which are activated to be reactive astrocytes and participate in tissue repairing, initiation and progression of neuroinflammatory diseases in CNS through neuroprotective or neurotoxic effects. The mechanism of reactive astrocytes is mainly related to their phenotypic transformation and activation of downstream inflammatory pathways. Exploring the characterization of reactive astrocytes and the underling mechanisms may provide unique insights into the pathogenesis of neuroinflammatory diseases and to identify potential targets of clinical treatment.

Key words: reactive astrocytes, central nervous system, neuroinflammation

CLC Number:

R392.3

LI Liya, QIN Pei. Advances of researches on astrocytes in inflammatory diseases of central nervous system[J]. Basic & Clinical Medicine, 2023, 43(4): 665-668.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.04.0665

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I4/665

References

[1]Williamson MR, Fuertes CJ, Dunn AK, et al. Reactive astrocytes facilitate vascular repair and remodeling after stroke[J]. Cell Rep, 2021, 35:109048. doi: 10.1016/j.celrep.2021.109048.
[2]Escartin C, Guillemaud O, Carrillo-de SMA. Questions and some answers on reactive astrocytes[J]. Glia, 2019, 67:2221-2247.
[3]Miyamoto N, Magami S, Inaba T, et al. The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion[J]. Glia, 2020, 68:1910-1924.
[4]Sarmiento SM, Larkin JR, Martin C, et al. STAT3-mediated astrocyte reactivity associated with brain metastasis contributes to neurovascular dysfunction[J]. Cancer Res, 2020, 80:5642-5655.
[5]Sui Y, Bian L, Ai Q, et al. Gastrodin inhibits inflammasome through the STAT3 signal pathways in TNA2 astrocytes and reactive astrocytes in experimentally induced cerebral ischemia in rats[J]. Neuromolecular Med, 2019, 21:275-286.
[6]Goshi N, Morgan RK, Lein PJ, et al. A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation[J]. J Neuroinflammation, 2020, 17:155. doi: 10.1186/s12974-020-01819-z.
[7]Wang X, Zhang Z, Zhu Z, et al. Photobiomodulation promotes repair following spinal cord injury by regulating the transformation of A1/A2 reactive astrocytes[J]. Front Neurosci, 2021, 15:768262. doi: 10.3389/fnins.2021.768262.
[8]Xie L, Zhang N, Zhang Q, et al. Inflammatory factors and amyloid beta-induced microglial polarization promote inflammatory crosstalk with astrocytes[J]. Aging (Albany NY), 2020, 12:22538-22549.
[9]Goetzl EJ, Schwartz JB, Abner EL, et al. High complement levels in astrocyte-derived exosomes of Alzheimer disease[J]. Ann Neurol, 2018, 83:544-552.
[10]Hou B, Zhang Y, Liang P, et al. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype[J]. Cell Death Dis, 2020, 11:377. doi: 10.1038/s41419-020-2565-2.
[11]Fulmer CG, VonDran MW, Stillman AA, et al. Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination[J]. J Neurosci, 2014, 34:8186-8196.
[12]Colombo E, Triolo D, Bassani C, et al. Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes[J]. Proc Natl Acad Sci U S A,2021,118:e2025804118. doi: 10.1073/pnas.2025804118.
[13]Liu Y, Ding XF, Wang XX, et al. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice[J]. BMC Complement Altern Med, 2019, 19:215. doi: 10.1186/s12906-019-2613-6.
[14]Carter SF, Herholz K, Rosa NP, et al. Astrocyte biomarkers in Alzheimer's disease[J]. Trends Mol Med, 2019, 25:77-95.
[15]Sarkar S, Biswas SC. Astrocyte subtype-specific approach to Alzheimer's disease treatment[J]. Neurochem Int, 2021,145:104956. doi: 10.1016/j.neuint.2021.104956.
[16]Diaz CB, Gangwani MR, Yu X, et al. Astrocyte molecular signatures in Huntington's disease[J]. Sci Transl Med,2019,11:eaaw8546. doi: 10.1126/scitranslmed.aaw8546.
[17]Saba J, Couselo FL, Turati J, et al. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin[J]. J Neuroinflammation, 2020, 17:290. doi: 10.1186/s12974-020-01965-4.
[18]Streubel-Gallasch L, Giusti V, Sandre M, et al.Parkinson's disease-associated LRRK2 interferes with astrocyte-mediated alpha-synuclein clearance[J]. Mol Neurobiol, 2021, 58:3119-3140.
[19]Dohgu S, Takata F, Matsumoto J, et al. Monomeric alpha-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro[J]. Microvasc Res, 2019,124:61-66.
[20]梁清. BDNF在ALS转基因小鼠活化星形胶质细胞中表达升高[J]. 基础医学与临床, 2020, 40: 1474-1478.
[21]Jiang LL, Zhu B, Zhao Y, et al. Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment[J]. J Clin Invest, 2019, 129:3103-3120.
[22]Ohgomori T, Yamasaki R, Takeuchi H, et al. Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Eur J Neurosci, 2017, 46:2001-2014.